GSK, Pfizer RSV shots to get warning of rare neurological disorder Posted on January 7, 2025 by wpadmin Hailshadow The U.S. FDA is ordering that respiratory syncytial virus (RSV) vaccines marketed by GSK (NYSE:GSK) and Pfizer (NYSE:PFE) contain a warning on labeling of the risk of developing the rare neurological disorder Guillain-Barré syndrome (“GBS”). The FDA Safety Communication impacts
